E
1,444.74
1.24 (0.09%)
| 前收盘价格 | 1,443.50 |
| 成交量 | 1,430,488 |
| 预期市盈率 (P/E Forward) | 29.01 |
| 价格/销量 (P/S) | 14.95 |
| 股市价格/股市净资产 (P/B) | 31.94 |
| 52周波幅 | |
| 股息率 (DY TTM) | 0.63% |
| 营业毛利率 | 22.67% |
| 营业利益率 (TTM) | 42.49% |
| 稀释每股收益 (EPS TTM) | 12.27 |
| 季度收入增长率 (YOY) | 45.20% |
| 季度盈利增长率 (YOY) | 23.00% |
| 总债务/股东权益 (D/E MRQ) | 243.61% |
| 流动比率 (MRQ) | 1.37 |
| 营业现金流 (OCF TTM) | 9.32 B |
| 杠杆自由现金流 (LFCF TTM) | -1.82 B |
| 资产报酬率 (ROA TTM) | 16.45% |
| 股东权益报酬率 (ROE TTM) | 77.28% |
新闻情绪
正面
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
- Lilly Bets Up to $1.5 Billion on Calytrix's Preclinical Antibody
负面
AIStockmoo 评分
| 价值 30% | 1.2 |
| 来自我们的 AI Insight 报告对预期回报与风险的评估。 参考 | NA |
| 相对其盈利增长,估值偏低。 参考 | |
| 当前股价隐含每年 22.3% 的盈利增长;公司业务可支撑约每年 15.0% 的增长。 参考 | |
| 接近其一贯估值。 参考 | |
| 负债高。盈利能力强。现金流为负。 参考 | |
| 资本回报远高于资本成本。资本回报上升。 参考 | |
| 时机 30% | 3.1 |
| 来自我们对走势图的 AI 技术分析。 参考 | NA |
| 过去一年呈上升趋势。股价接近52周高点。 参考 | |
| 近期出现看跌反转形态:射击之星。 参考 | |
| 您持有期的趋势 参考 | NA |
| 市场情绪 20% | 0.0 |
| 近期没有目标价,因此依据目标价的调整方向。 参考 | |
| 近期新闻好坏参半或中性。 参考 | |
| 聪明钱 20% | -2.7 |
| 多名内部人士近期净卖出。股价高于内部人士的卖出价。 参考 | |
| 机构在最新13F申报中净-23.90%的股份:2,501家增持,1,954家减持(截至30 Sep 2026的季度)。 参考 | |
| 市场和行业状况中性。 | |
| 市场环境偏谨慎。 参考 | |
| 行业表现优于大市。 | |
| 各支柱方向不一,评分因此减弱。 | |
| 不计入评分 | |
| 股价高于其52周平均水平。5年来上涨。 参考 | |
| 短、中、长期趋势均向上。短期动能上升。 参考 | |
| 股价接近阻力位。支撑与阻力水平趋降。 参考 | |
| 最终评分 | 0.70 |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - General (US) | 混合的 | 看涨 |
| Drug Manufacturers - General (全球的) | 混合的 | 看涨 | |
| 股票 | Eli Lilly and Company | 混合的 | 看涨 |
相关股票
| 股票 | 市值 | DY | P/E(TTM) | P/B |
|---|---|---|---|---|
| LLY | - | 0.63% | - | 31.94 |
| NVS | - | 3.20% | - | 8.13 |
| MRK | - | 2.31% | - | 8.12 |
| JNJ | - | 1.92% | - | 8.44 |
| PFE | - | 6.00% | - | 1.85 |
| ABBV | - | 3.18% | - | - |
|
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - General |
| 投资方式 | Large Growth |
| 内部持股比例 | 0.16% |
| 机构持股比例 | 83.96% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Lilly Endowment Inc | 30 Sep 2026 | 90,066,978 |
| Pnc Financial Services Group, Inc. | 30 Sep 2026 | 51,295,197 |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| JONSSON PATRIK | - | 1,432.29 | -704 | -1,008,332 |
| RICKS DAVID A | - | 1,409.38 | -23,538 | -33,173,986 |
| 累积净数量 | -24,242 | |||
| 累积净值 ($) | -34,182,319 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 1,410.05 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| JONSSON PATRIK | 职员 | 10 Nov 2026 | 处理 (-) | 704 | 1,432.29 | 1,008,332 |
| RICKS DAVID A | 职员 | 03 Nov 2026 | 处理 (-) | 23,538 | 1,409.38 | 33,173,986 |
机构
机构持股比例: 98.05%
| 持仓变动 | 机构数 | 股数 |
|---|---|---|
| 增持 | 2,501 | 29,582,823 |
| 减持 | 1,954 | 194,259,902 |
| 新建仓 | 246 | 6,746,969 |
| 清仓 | 175 | 66,935,014 |
来源:经Nasdaq的SEC 13F申报,最新申报截至30 Sep 2026。申报在每季结束后45天内陆续提交。
3 正面
4 负面
8 中性
| 日期 | 类型 | 细节 |
|---|---|---|
| 16 Nov 2026 | Yahoo Finance |
Lilly Bets Up to $1.5 Billion on Calytrix's Preclinical Antibody
The deal is Lilly's second blood cancer acquisition this year, after Ajax Therapeutics… |
| 16 Nov 2026 | Yahoo Finance |
Eli Lilly Makes $1.5 Billion Move Beyond Weight-Loss Drugs
Calytrix is developing an early-stage antibody treatment for essential thrombocythemia and myelofibrosis. |
| 16 Nov 2026 | Yahoo Finance |
Eli Lilly is trouncing Nvidia — and the weight-loss drug trade is beating AI again
Since its Oct. 6 record, Nvidia has shed more than $1.7 trillion in market value. Eli Lilly has added more than $250 billion over the same stretch, a gain topped only by Apple among the market's biggest stocks. |
| 16 Nov 2026 | Yahoo Finance |
CVS Sees a Possible Break-Even Point for GLP-1s
Drugmakers could gain patients while earning less per prescription. |
| 16 Nov 2026 | Yahoo Finance |
CVS white paper aims to pressure drugmakers to lower GLP-1 prices
GLP-1s would save employers money in the long term if priced at $350 a month or less, the company found. “I would love to see this pressure [drugmakers] to bring down prices to something rational,” CMO Amy Compton-Phillips said. |
| 16 Nov 2026 | Yahoo Finance |
Anti-Obesity Drugs Market Companies Analysis 2027: Eli Lilly and Novo Nordisk Lead as Pfizer, Roche and Amgen Invest Billions to Challenge Them in a Market Headed for USD 64.96 Billion by 2035
Lilly's Mounjaro and Zepbound Earn USD 16.1 Billion in One Quarter, Novo's Obesity Sales Rise 22% and Oral GLP-1 Pills Open a New Front: Precedence Research Company Intelligence on Leaders, Pipelines, Investments and DealsOttawa, Nov. 16, 2026 (GLOBE NEWSWIRE) -- The global anti-obesity drugs… |
| 16 Nov 2026 | Yahoo Finance |
Eli Lilly to acquire Calytrix Bio in deal worth up to $1.5 billion
Eli Lilly and Co (NYSE:LLY) has agreed to acquire privately held biotechnology company Calytrix Bio for up to $1.5 billion in cash, expanding its efforts to develop treatments for rare blood disorders and strengthen its presence in haematology. Under the definitive agreement, Calytrix… |
| 16 Nov 2026 | Yahoo Finance |
Eli Lilly to Acquire Calytrix Bio for Up to $1.5 Billion to Expand Blood Cancer Portfolio
Eli Lilly and Company (NYSE:LLY) has agreed to acquire privately held biotechnology company Calytrix Bio in a cash transaction valued at up to $1. 5 billion, expanding its development portfolio of treatments for rare blood cancers. |
| 16 Nov 2026 | Yahoo Finance |
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. |
| 16 Nov 2026 | Yahoo Finance |
Lilly adds to buyout streak with $1.5B purchase of startup Calytrix
Lilly’s 15th announced company acquisition this year — by far the most in the biopharmaceutical sector — centers around a precision therapy for rare blood disorders known as myeloproliferative neoplasms. |
| 16 Nov 2026 | Yahoo Finance |
What Does Eli Lilly (LLY) Reveal At ObesityWeek 2026 About Its Growth Path?
Eli Lilly (NYSE:LLY) released new clinical data at ObesityWeek 2026 on Zepbound, Foundayo, EloraTZP, and retatrutide. The update included late-stage obesity and cardiometabolic results that covered weight loss, metabolic markers, and related chronic conditions. Data presented highlighted efficacy… |
| 16 Nov 2026 | Yahoo Finance |
State Street Health Care SPDR (XLV) Sells Eli Lilly and J&J on Nov. 12
The fund sold $300.3 million of stock, cutting all 60 positions and adding nothing, as its assets stood at $50.56 billion. |
| 16 Nov 2026 | Yahoo Finance |
ETFs Are Net Sellers of Eli Lilly (LLY) on Nov. 12
Eli Lilly (LLY) drew $300.9 million in net ETF selling Thursday. |
| 16 Nov 2026 | Yahoo Finance |
Big-name investors pour $100M into DNA therapeutics developer Seawolf
The startup, which also just disclosed an up to $1.2 billion partnership with Sanofi, is backed by Versant, MPM BioImpact, Eli Lilly and Novartis’ venture arm. |
| 09 Nov 2026 | CNBC |
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity. |
| 02 Oct 2026 | CNBC | Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s |
| 30 Sep 2026 | CNBC | Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial |
| 30 Sep 2026 | CNBC | People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study |
| 25 Sep 2026 | CNBC | Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s |
| 21 Sep 2026 | CNBC | Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs |
| 21 Sep 2026 | CNBC | Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production |
| 14 Sep 2026 | CNBC | Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy |
| 31 Aug 2026 | CNBC | Trump strikes new drug pricing deals with nine midsized drugmakers |
| 显示更多 | ||
| 股息率 (DY TTM) | 0.63% |
| 5年平均股息收益率 | 0.78% |
| 股息支付比率 | 43.94% |
| 除息日 | 公告日期 | 支付日期 | 详情 |
|---|---|---|---|
| 14 Feb 2025 | 09 Dec 2024 | 10 Mar 2025 | 1.5 现金 |
| 15 Nov 2024 | 28 Oct 2024 | 10 Dec 2024 | 1.3 现金 |
| 15 Aug 2024 | 24 Jun 2024 | 10 Sep 2024 | 1.3 现金 |
| 15 May 2024 | 06 May 2024 | 10 Jun 2024 | 1.3 现金 |
| 14 Feb 2024 | 08 Dec 2023 | 08 Mar 2024 | 1.3 现金 |
| 14 Nov 2023 | 01 Nov 2023 | 08 Dec 2023 | 1.13 现金 |
| 14 Aug 2023 | 26 Jun 2023 | 08 Sep 2023 | 1.13 现金 |
| 12 May 2023 | 01 May 2023 | 09 Jun 2023 | 1.13 现金 |
| 14 Feb 2023 | 12 Dec 2022 | 10 Mar 2023 | 1.13 现金 |
| 14 Nov 2022 | 17 Oct 2022 | 09 Dec 2022 | 0.98 现金 |
| 12 Aug 2022 | 27 Jun 2022 | 09 Sep 2022 | 0.98 现金 |
| 13 May 2022 | 02 May 2022 | 10 Jun 2022 | 0.98 现金 |
| 14 Feb 2022 | 13 Dec 2021 | 10 Mar 2022 | 0.98 现金 |
| 12 Nov 2021 | 18 Oct 2021 | 10 Dec 2021 | 0.85 现金 |
| 12 Aug 2021 | 29 Jun 2021 | 10 Sep 2021 | 0.85 现金 |
| 13 May 2021 | 03 May 2021 | 10 Jun 2021 | 0.85 现金 |
| 11 Feb 2021 | 14 Dec 2020 | 10 Mar 2021 | 0.85 现金 |
| 12 Nov 2020 | 19 Oct 2020 | 10 Dec 2020 | 0.74 现金 |
| 13 Aug 2020 | 15 Jul 2020 | 10 Sep 2020 | 0.74 现金 |
| 14 May 2020 | 04 May 2020 | 10 Jun 2020 | 0.74 现金 |
| 13 Feb 2020 | 16 Dec 2019 | 10 Mar 2020 | 0.74 现金 |
| 14 Nov 2019 | 22 Oct 2019 | 10 Dec 2019 | 0.645 现金 |
| 14 Aug 2019 | 20 Jun 2019 | 10 Sep 2019 | 0.645 现金 |
| 16 May 2019 | 07 May 2019 | 10 Jun 2019 | 0.645 现金 |
| 14 Feb 2019 | 19 Dec 2018 | 08 Mar 2019 | 0.645 现金 |
| 14 Nov 2018 | 16 Oct 2018 | 10 Dec 2018 | 0.5625 现金 |
| 14 Aug 2018 | 19 Jun 2018 | 10 Sep 2018 | 0.5625 现金 |
| 16 May 2018 | 07 May 2018 | 08 Jun 2018 | 0.5625 现金 |
| 14 Feb 2018 | 11 Dec 2017 | 09 Mar 2018 | 0.5625 现金 |
| 14 Nov 2017 | 16 Oct 2017 | 08 Dec 2017 | 0.52 现金 |
| 11 Aug 2017 | 19 Jun 2017 | 08 Sep 2017 | 0.52 现金 |
| 11 May 2017 | 01 May 2017 | 09 Jun 2017 | 0.52 现金 |
| 13 Feb 2017 | 12 Dec 2016 | 10 Mar 2017 | 0.52 现金 |
| 10 Nov 2016 | 17 Oct 2016 | 09 Dec 2016 | 0.51 现金 |
| 11 Aug 2016 | 20 Jun 2016 | 09 Sep 2016 | 0.51 现金 |
| 11 May 2016 | 02 May 2016 | 10 Jun 2016 | 0.51 现金 |
| 10 Feb 2016 | 08 Dec 2015 | 10 Mar 2016 | 0.51 现金 |
| 10 Nov 2015 | 19 Oct 2015 | 10 Dec 2015 | 0.5 现金 |
| 12 Aug 2015 | 15 Jun 2015 | 10 Sep 2015 | 0.5 现金 |
| 14 May 2015 | 04 May 2015 | 10 Jun 2015 | 0.5 现金 |
| 11 Feb 2015 | 15 Dec 2014 | 10 Mar 2015 | 0.5 现金 |
| 12 Nov 2014 | 20 Oct 2014 | 10 Dec 2014 | 0.49 现金 |
| 13 Aug 2014 | 16 Jun 2014 | 10 Sep 2014 | 0.49 现金 |
| 13 May 2014 | 05 May 2014 | 10 Jun 2014 | 0.49 现金 |
| 12 Feb 2014 | 16 Dec 2013 | 10 Mar 2014 | 0.49 现金 |
| 13 Nov 2013 | 21 Oct 2013 | 10 Dec 2013 | 0.49 现金 |
| 13 Aug 2013 | 18 Jun 2013 | 10 Sep 2013 | 0.49 现金 |
| 14 May 2013 | 03 May 2013 | 10 Jun 2013 | 0.49 现金 |
| 13 Feb 2013 | 17 Dec 2012 | 08 Mar 2013 | 0.49 现金 |
| 13 Nov 2012 | 15 Oct 2012 | 10 Dec 2012 | 0.49 现金 |
| 13 Aug 2012 | 19 Jun 2012 | 10 Sep 2012 | 0.49 现金 |
| 13 Feb 2012 | 12 Dec 2011 | 09 Mar 2012 | 0.49 现金 |
| 10 Nov 2011 | 17 Oct 2011 | 09 Dec 2011 | 0.49 现金 |
| 11 Aug 2011 | 20 Jun 2011 | 09 Sep 2011 | 0.49 现金 |
| 11 May 2011 | 18 Apr 2011 | 10 Jun 2011 | 0.49 现金 |
| 11 Feb 2011 | 13 Dec 2010 | 10 Mar 2011 | 0.49 现金 |
| 10 Nov 2010 | 18 Oct 2010 | 10 Dec 2010 | 0.49 现金 |
| 11 Aug 2010 | 21 Jun 2010 | 10 Sep 2010 | 0.49 现金 |
| 12 May 2010 | 19 Apr 2010 | 10 Jun 2010 | 0.49 现金 |
| 10 Feb 2010 | 14 Dec 2009 | 10 Mar 2010 | 0.49 现金 |
| 10 Nov 2009 | 19 Oct 2009 | 10 Dec 2009 | 0.49 现金 |
| 12 Aug 2009 | 22 Jun 2009 | 10 Sep 2009 | 0.49 现金 |
| 13 May 2009 | 20 Apr 2009 | 10 Jun 2009 | 0.49 现金 |
| 11 Feb 2009 | 15 Dec 2008 | 10 Mar 2009 | 0.49 现金 |
| 12 Nov 2008 | 20 Oct 2008 | 10 Dec 2008 | 0.47 现金 |
| 13 Aug 2008 | 20 Jun 2008 | 10 Sep 2008 | 0.47 现金 |
| 13 Feb 2008 | 17 Dec 2007 | 10 Mar 2008 | 0.47 现金 |
| 13 Nov 2007 | 15 Oct 2007 | 10 Dec 2007 | 0.425 现金 |
| 13 Aug 2007 | 21 Jun 2007 | 10 Sep 2007 | 0.425 现金 |
| 11 May 2007 | 16 Apr 2007 | 08 Jun 2007 | 0.425 现金 |
| 13 Feb 2007 | 18 Dec 2006 | 09 Mar 2007 | 0.425 现金 |
| 13 Nov 2006 | 16 Oct 2006 | 08 Dec 2006 | 0.4 现金 |
| 11 Aug 2006 | 26 Jun 2006 | 08 Sep 2006 | 0.4 现金 |
| 11 May 2006 | 24 Apr 2006 | 09 Jun 2006 | 0.4 现金 |
| 13 Feb 2006 | 19 Dec 2005 | 10 Mar 2006 | 0.4 现金 |
| 10 Nov 2005 | 17 Oct 2005 | 09 Dec 2005 | 0.38 现金 |
| 11 Aug 2005 | 24 Jun 2005 | 09 Sep 2005 | 0.38 现金 |
| 11 May 2005 | 18 Apr 2005 | 10 Jun 2005 | 0.38 现金 |
| 11 Feb 2005 | 20 Dec 2004 | 10 Mar 2005 | 0.38 现金 |
| 10 Nov 2004 | 18 Oct 2004 | 10 Dec 2004 | 0.355 现金 |
| 11 Aug 2004 | 28 Jun 2004 | 10 Sep 2004 | 0.355 现金 |
| 12 May 2004 | 19 Apr 2004 | 10 Jun 2004 | 0.355 现金 |
| 11 Feb 2004 | 15 Dec 2003 | 10 Mar 2004 | 0.355 现金 |
| 12 Nov 2003 | 20 Oct 2003 | 10 Dec 2003 | 0.335 现金 |
| 13 Aug 2003 | 23 Jun 2003 | 10 Sep 2003 | 0.335 现金 |
| 13 May 2003 | 28 Apr 2003 | 10 Jun 2003 | 0.335 现金 |
| 12 Feb 2003 | 16 Dec 2002 | 10 Mar 2003 | 0.335 现金 |
| 13 Nov 2002 | 21 Oct 2002 | 10 Dec 2002 | 0.31 现金 |
| 13 Aug 2002 | 24 Jun 2002 | 10 Sep 2002 | 0.31 现金 |
| 13 May 2002 | 15 Apr 2002 | 10 Jun 2002 | 0.31 现金 |
| 13 Feb 2002 | 17 Dec 2001 | 08 Mar 2002 | 0.31 现金 |
| 13 Nov 2001 | 15 Oct 2001 | 10 Dec 2001 | 0.28 现金 |
| 13 Aug 2001 | 25 Jun 2001 | 10 Sep 2001 | 0.28 现金 |
| 11 May 2001 | 16 Apr 2001 | 11 Jun 2001 | 0.28 现金 |
| 13 Feb 2001 | 18 Dec 2000 | 09 Mar 2001 | 0.28 现金 |
| 13 Nov 2000 | 16 Oct 2000 | 11 Dec 2000 | 0.26 现金 |
| 11 Aug 2000 | 26 Jun 2000 | 11 Sep 2000 | 0.26 现金 |
| 11 May 2000 | 17 Apr 2000 | 09 Jun 2000 | 0.26 现金 |
| 11 Feb 2000 | 20 Dec 1999 | 10 Mar 2000 | 0.26 现金 |
| 10 Nov 1999 | 18 Oct 1999 | 10 Dec 1999 | 0.23 现金 |
| 11 Aug 1999 | 19 Jul 1999 | 10 Sep 1999 | 0.23 现金 |
| 12 May 1999 | 19 Apr 1999 | 10 Jun 1999 | 0.23 现金 |
| 10 Feb 1999 | 21 Dec 1998 | 10 Mar 1999 | 0.23 现金 |
| 10 Nov 1998 | 20 Oct 1998 | 10 Dec 1998 | 0.2 现金 |
| 12 Aug 1998 | 20 Jul 1998 | 10 Sep 1998 | 0.2 现金 |
| 13 May 1998 | 20 Apr 1998 | 10 Jun 1998 | 0.2 现金 |
| 11 Feb 1998 | 15 Dec 1997 | 10 Mar 1998 | 0.2 现金 |
| 12 Nov 1997 | 15 Sep 1997 | 10 Dec 1997 | 0.2 现金 |
| 13 Aug 1997 | 21 Jul 1997 | 10 Sep 1997 | 0.36 现金 |
| 13 May 1997 | 21 Apr 1997 | 10 Jun 1997 | 0.36 现金 |
| 12 Feb 1997 | 16 Dec 1996 | 10 Mar 1997 | 0.36 现金 |
| 13 Nov 1996 | 21 Oct 1996 | 10 Dec 1996 | 0.3425 现金 |
| 13 Aug 1996 | 15 Jul 1996 | 10 Sep 1996 | 0.3425 现金 |
| 13 May 1996 | 15 Apr 1996 | 10 Jun 1996 | 0.3425 现金 |
| 13 Feb 1996 | 18 Dec 1995 | 11 Mar 1996 | 0.3425 现金 |
| 13 Nov 1995 | 17 Oct 1995 | 11 Dec 1995 | 0.685 现金 |
| 11 Aug 1995 | 17 Jul 1995 | 11 Sep 1995 | 0.645 现金 |
| 09 May 1995 | 17 Apr 1995 | 12 Jun 1995 | 0.645 现金 |
| 显示更多 | |||
每年股息收益率
| 年份 | 每年总股息 ($) | 频率/年份 | 收益率 % |
|---|---|---|---|
| 2025 | 1.50 | 1 | 0.14 |
| 2024 | 5.20 | 4 | 0.67 |
| 2023 | 4.52 | 4 | 0.78 |
| 2022 | 3.92 | 4 | 1.07 |
| 2021 | 3.40 | 4 | 1.23 |
| 2020 | 2.96 | 4 | 1.75 |
| 2019 | 2.58 | 4 | 1.96 |
| 2018 | 2.25 | 4 | 1.94 |
| 2017 | 2.08 | 4 | 2.46 |
| 2016 | 2.04 | 4 | 2.77 |
| 2015 | 2.00 | 4 | 2.37 |
| 2014 | 1.96 | 4 | 2.84 |
| 2013 | 1.96 | 4 | 3.84 |
| 2012 | 1.47 | 3 | 2.98 |
| 2011 | 1.96 | 4 | 4.72 |
| 2010 | 1.96 | 4 | 5.59 |
| 2009 | 1.96 | 4 | 5.49 |
| 2008 | 1.41 | 3 | 3.50 |
| 2007 | 1.70 | 4 | 3.18 |
| 2006 | 1.60 | 4 | 3.07 |
| 2005 | 1.52 | 4 | 2.69 |
| 2004 | 1.42 | 4 | 2.50 |
| 2003 | 1.34 | 4 | 1.91 |
| 2002 | 1.24 | 4 | 1.95 |
| 2001 | 1.12 | 4 | 1.43 |
| 2000 | 1.04 | 4 | 1.12 |
| 1999 | 0.920 | 4 | 1.38 |
| 1998 | 0.800 | 4 | 0.90 |
| 1997 | 1.28 | 4 | 1.84 |
| 1996 | 1.37 | 4 | 3.75 |
| 1995 | 1.98 | 3 | 7.02 |
| 显示更多 | |||
投资组合